ADAMTS18

Chr 16AR

ADAM metallopeptidase with thrombospondin type 1 motif 18

Also known as: ADAMTS21, KNO2, MMCAT

This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may regulate hemostatic balance and function as a tumor suppressor. Mutations in this gene may be associated with microcornea, myopic chorioretinal atrophy, and telecanthus (MMCAT) and cone-rod dystrophy in human patients. [provided by RefSeq, May 2016]

OMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.931 OMIM phenotype
Clinical SummaryADAMTS18
🧬
Gene-Disease Validity (ClinGen)
microcornea-myopic chorioretinal atrophy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
65 unique Pathogenic / Likely Pathogenic· 647 VUS of 1310 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.93LOEUF
pLI 0.000
Z-score 2.07
OE 0.74 (0.600.93)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-3.51Z-score
OE missense 1.38 (1.311.46)
919 obs / 664.5 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.74 (0.600.93)
00.351.4
Missense OE?1.38 (1.311.46)
00.61.4
Synonymous OE?1.50
01.21.6
LoF obs/exp: 56 / 75.4Missense obs/exp: 919 / 664.5Syn Z: -6.37
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveADAMTS18-related microcornea, myopic chorioretinal atrophy, and telecanthusLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6260th %ile
GOF
0.5268th %ile
LOF
0.4234th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

1310 submitted variants in ClinVar

Classification Summary

Pathogenic47
Likely Pathogenic18
VUS647
Likely Benign509
Benign56
Conflicting18
47
Pathogenic
18
Likely Pathogenic
647
VUS
509
Likely Benign
56
Benign
18
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
43
1
3
0
47
Likely Pathogenic
15
0
3
0
18
VUS
5
606
33
3
647
Likely Benign
0
42
184
283
509
Benign
0
16
16
24
56
Conflicting
18
Total636652393101,295

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

33 pathogenic / likely-pathogenic (of 76) ClinVar copy-number / structural variants overlap ADAMTS18 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ADAMTS18 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →